Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-05-17 @ 4:21 PM
Study NCT ID:
NCT05080556
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2021-06-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer
Sponsor:
University College, London
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
136618
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None